BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19748118)

  • 1. NPY regulation of bone remodelling.
    Lee NJ; Herzog H
    Neuropeptides; 2009 Dec; 43(6):457-63. PubMed ID: 19748118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
    Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
    J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.
    Shi YC; Baldock PA
    Bone; 2012 Feb; 50(2):430-6. PubMed ID: 22008645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
    Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
    J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts.
    Pedrazzini T
    Neuropeptides; 2004 Aug; 38(4):267-75. PubMed ID: 15337379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.
    Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H
    J Bone Miner Res; 2006 Oct; 21(10):1600-7. PubMed ID: 16995815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the reviews on neuropeptide Y.
    Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?
    Vezzani A; Sperk G
    Neuropeptides; 2004 Aug; 38(4):245-52. PubMed ID: 15337376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of neuropeptide Y receptors for the treatment of obesity.
    Sato N; Ogino Y; Mashiko S; Ando M
    Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and osteoblast differentiation--the balance between the neuro-osteogenic network and local control.
    Franquinho F; Liz MA; Nunes AF; Neto E; Lamghari M; Sousa MM
    FEBS J; 2010 Sep; 277(18):3664-74. PubMed ID: 20681986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.
    Zhang L; Bijker MS; Herzog H
    Pharmacol Ther; 2011 Jul; 131(1):91-113. PubMed ID: 21439311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y and seizures: effects of exogenously applied ligands.
    Woldbye DP; Kokaia M
    Neuropeptides; 2004 Aug; 38(4):253-60. PubMed ID: 15337377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.
    Baldock PA; Allison SJ; Lundberg P; Lee NJ; Slack K; Lin EJ; Enriquez RF; McDonald MM; Zhang L; During MJ; Little DG; Eisman JA; Gardiner EM; Yulyaningsih E; Lin S; Sainsbury A; Herzog H
    J Biol Chem; 2007 Jun; 282(26):19092-102. PubMed ID: 17491016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of NPY receptors in the hypothalamus.
    Fetissov SO; Kopp J; Hökfelt T
    Neuropeptides; 2004 Aug; 38(4):175-88. PubMed ID: 15337370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
    Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
    J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.